论文部分内容阅读
目的 :探究降钙素治疗骨质疏松症的临床疗效。方法 :选择2014年6月-2015年6月来我院就诊的老年骨质疏松患者106例为研究对象,将其分成两组,对照组使用钙尔奇-D片,以此为基础,观察组使用鲑鱼降钙素,3个月后,观察两组患者的骨密度,生活能力改善和疼痛控制情况。结果 :经治疗后治疗组骨密度明显高于对照组,组间数据存在统计学意义,P<0.05.和对照组相比,治疗组患者的生活质量和疼痛控制情况明显较好,组间数据存在统计学意义,P<0.05.结论:对于老年骨质疏松患者,使用鲑鱼降钙素,能够全面提升生活品质,缓解临床症状,增加骨密度,对疾病的预后和好转有着十分重要的临床意义,值得进一步推广。
Objective: To investigate the clinical efficacy of calcitonin in the treatment of osteoporosis. Methods: A total of 106 senile patients with osteoporosis who came to our hospital from June 2014 to June 2015 were selected as study subjects and divided into two groups. The control group was treated with Calcium-D tablets. Based on this observation, The group used salmon calcitonin, and three months later, the bone mineral density, viability, and pain control were observed in both groups. Results: Compared with the control group, the BMD of the treatment group was significantly higher than that of the control group, P <0.05.Compared with the control group, the quality of life and pain control in the treatment group were significantly better, the inter-group data P <0.05.Conclusion: The use of salmon calcitonin in elderly patients with osteoporosis can improve the quality of life, relieve the clinical symptoms and increase the bone density, which is of great clinical significance for the prognosis and improvement of the disease , Worth further promotion.